≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Cleft lip, lip and palate or palate

DOID EFO Endpoint Browser PheWeb

Q17_CLEFT_LIP_CLEFT_PALATE

cleft lip: ['Congenital defect in the upper lip where the maxillary prominence fails to merge with the merged medial nasal prominences. It is thought to be caused by faulty migration of the mesoderm in the head region.']

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

  • not Q17_CLEFT_PALATE_EXCLUDE
519067

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — Q35-Q37
  • Hospital discharge: ICD-9 — 749
  • Hospital discharge: ICD-8 — 74900|74910|74911|74912|74913|74920|74924|74929
  • Cause of death: ICD-10 — Q35-Q37
  • Cause of death: ICD-9 — 749
  • Cause of death: ICD-8 — 74900|74910|74911|74912|74913|74920|74924|74929

2 out of 7 registries used, show all original rules.

628

4. Check minimum number of events

None

628

5. Include endpoints

None

628

6. Filter based on genotype QC (FinnGen only)

603

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF7

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 8348 4172 4162
Only index persons 6932 3502 3430
Unadjusted period prevalence (%)
Whole population 0.12 0.12 0.12
Only index persons 0.13 0.13 0.13
Median age at first event (years)
Whole population 1.21 1.31 1.00
Only index persons 1.51 1.76 1.27

-FinnGen-

Key figures

All Female Male
Number of individuals 603 372 231
Unadjusted period prevalence (%) 0.12 0.13 0.11
Median age at first event (years) 2.70 2.47 3.06

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
626
Matched controls
6259
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q35.1
ICD-10 Finland
Cleft hard palate
2710.2
200.1
183
*
74900
ICD-8 Finland
Cleft palate and cleft lip, Cleft palate
+∞
187.1
170
*
Q37.1
ICD-10 Finland
Cleft hard palate with unilateral cleft lip
+∞
158.2
145
*
4122
FHL
Tympanostomy (tympanic tube)
16.6
125.1
112
81
74920
ICD-8 Finland
Cleft palate and cleft lip, Cheilognathopalatoschisis unilateralis
+∞
101.9
95
*
4364
FHL
Pharyngeal tongue plastic
+∞
90.9
85
*
7490A
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate[PALATOSCHISIS COMPLETA]
+∞
88.7
83
*
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
9.3
82.6
109
139
4362
FHL
Nozzle reconstruction
+∞
76.7
72
*
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
11.7
73.3
79
76
4361
FHL
Lip plastic or reconstruction due to cleft lip
+∞
71.2
67
*
7492A
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate with cleft lip[CHEILOPALATOSCHISIS UNILATERALIS COMPLETA]
+∞
71.2
67
*
EB1MA
NOMESCO Finland
Cephalometry with X-ray
9.2
70.9
93
117
SBB10
NOMESCO Finland
Dental impressions
5.5
69.4
165
385
SAA04
NOMESCO Finland
Special examination of mouth
7.0
68.5
117
199
SJX10
NOMESCO Finland
Orthodontic treatment/control appointment, short
7.4
68.0
109
173
EAB30
NOMESCO Finland
Correction of cleft lip
+∞
65.8
62
*
EBB10
NOMESCO Finland
Insertion of dental implant
19.5
65.3
52
29
Q37.0
ICD-10 Finland
Cleft hard palate with bilateral cleft lip
+∞
62.6
59
*
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
14.5
61.2
57
43
Q35.71
ICD-10 Finland
Submucous cleft palate
587.3
55.5
54
*
Q35.9
ICD-10 Finland
Cleft palate, unspecified
587.3
55.5
54
*
K00.00
ICD-10 Finland
Hypodontia
12.5
51.3
52
45
38401
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) chronica adhaesiva
20.7
50.6
39
20
74929
ICD-8 Finland
Cleft palate and cleft lip, Unspecified
+∞
48.6
46
*
1450
FHL
Otomicroscopy
20.6
47.9
37
19
H65.3
ICD-10 Finland
Chronic mucoid otitis media
7.1
47.5
76
119
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
14.3
47.2
44
33
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
6.6
46.7
81
138
Q36.9
ICD-10 Finland
Cleft lip, unilateral
+∞
46.4
44
*
ECB17
NOMESCO Finland
Operation of gingival cleft
+∞
45.4
43
*
4368
FHL
Closing the fistula of the mouth
+∞
44.3
42
*
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
6.2
43.3
80
145
7490C
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate[PALATOSCHISIS SUBMUCOSAE]
+∞
43.2
41
*
4367
FHL
Bone transfer to the upper jaw
+∞
42.2
40
*
7490B
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate[PALATOSCHISIS INCOMPLETA]
+∞
42.2
40
*
74924
ICD-8 Finland
Cleft palate and cleft lip, Cheilognathopalatoschisis bilateralis
+∞
42.2
40
*
SJD00
NOMESCO Finland
Removal and/or reactivation of orthodontic arch wire
6.2
39.7
72
128
SJD20
NOMESCO Finland
Placement of modified orthodontic arch wire
7.4
37.5
57
84
7492C
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate with cleft lip[CHEILOPALATOSCHISIS BILATERALIS COMPLETA]
+∞
36.8
35
*
SJC50
NOMESCO Finland
Removal of fixed orthodontic appliance with at least 7 brackets
6.4
36.3
63
107
4365
FHL
Correction of nasal deformity
+∞
35.8
34
*
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prosthodontic work
8.0
35.7
50
67
EEC05
NOMESCO Finland
Le Fort I osteotomy
54.7
34.9
41
8
4451
FHL
Guitar cutting
5.0
34.2
79
175
ZSZ10
NOMESCO Finland
Secondary repair operation
179.4
33.0
34
*
UDC00
NOMESCO Finland
Ear microscopy
4.5
32.7
87
216
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
4.1
30.7
94
259
38402
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) non definita
11.2
30.7
33
31
74910
ICD-8 Finland
Cleft palate and cleft lip, Cheiloschisis unilateralis
+∞
30.5
29
*
SJB00
NOMESCO Finland
Fitting of removable appliance incl. patient instructions
5.5
30.3
62
123
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
5.9
28.7
54
99
SJD30
NOMESCO Finland
Demanding placement of orthodontic arch wire
7.6
27.4
40
56
DLW00
NOMESCO Finland
Correction of cleft nose
+∞
27.3
26
*
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
35.8
26.8
34
10
EBB15
NOMESCO Finland
Insertion of dental implant abutment
28.4
26.0
35
13
Q35.3
ICD-10 Finland
Cleft soft palate
271.2
25.9
26
*
EHC10
NOMESCO Finland
Plastic repair of oronasal or oroantral fistula of palate
271.2
25.9
26
*
EHC40
NOMESCO Finland
Repair of submucous cleft palate
271.2
25.9
26
*
4121
FHL
Tympanic puncture or parasentosis in general anesthesia or operating room
9.1
25.6
32
37
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
8.1
24.9
34
44
SJD40
NOMESCO Finland
Placement of prefabricated palatal or lingual arch
4.6
22.0
55
129
Q37.99
ICD-10 Finland
Cleft palate with cleft lip NOS
+∞
22.0
21
*
74912
ICD-8 Finland
Cleft palate and cleft lip, Cheilognathoschisis unilateralis
+∞
22.0
21
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.3
21.1
250
1416
SJB60
NOMESCO Finland
Adjustment and grinding of removable appliance
5.5
21.1
42
81
4366
FHL
Upper jaw scar repair surgery
+∞
20.9
20
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.9
20.8
114
449
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
4.8
20.7
48
106
SJD10
NOMESCO Finland
Placement of orthodontic arch wire
4.5
20.4
52
124
ENC80
NOMESCO Finland
Plastic operation of soft palate for voice distubance
+∞
19.9
19
*
ECB40
NOMESCO Finland
Surgical treatment of fracture of alveolus
30.1
19.8
26
9
ZXB10
NOMESCO Finland
Medial
21.6
18.8
27
13
DLD20
NOMESCO Finland
Rhinoplasty
39.7
18.7
23
6
R1260
NOMESCO Finland
Evaluation of communicative skills
8.1
18.4
25
32
Z2221
NOMESCO Finland
Medical doctor
2.2
18.3
211
1169
9808
FHL
Bone graft
185.0
17.6
18
*
K07.14
ICD-10 Finland
Retrognaty, maxillary
21.6
17.4
25
12
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.5
16.7
118
525
H65.9
ICD-10 Finland
Nonsuppurative otitis media, unspecified
7.5
16.6
24
33
4347
FHL
Osteotomy of the upper jaw
174.4
16.6
17
*
ZZG00
NOMESCO Finland
Graft of cartilage
174.4
16.6
17
*
WZC00
NOMESCO Finland
Treatment plan or consultation
2.0
16.1
264
1655
Q37.90
ICD-10 Finland
Unspecified cheft palate with cleft lip, unilateral
+∞
15.7
15
*
SJC02
NOMESCO Finland
Positioning and fixed attachment of brackets
5.2
15.4
32
64
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
20.7
15.2
22
11
SAA03
NOMESCO Finland
Extended examination of mouth
1.9
14.7
317
2165
SXC05
NOMESCO Finland
Other oral or dental procedure
2.7
14.6
85
343
4204
FHL
Molding of the cartilaginous part of the nose
153.4
14.5
15
*
38110
ICD-8 Finland
Otitis media without mention of mastoiditis, Chronic
20.6
13.9
20
10
7491B
ICD-9 Finland
Cleft palate and cleft lip, Cleft lip[CHEILOSCHISIS UNILATERALIS INCOMPLETA]
+∞
13.6
13
*
ZSZ00
NOMESCO Finland
Primary repair operation
+∞
13.6
13
*
SJA04
NOMESCO Finland
Very demanding workplan for orthodontic treatment
34.9
13.6
17
5
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
13.1
210
1287
SJX20
NOMESCO Finland
Orthodontic treatment/control appointment
4.2
13.0
35
87
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
19.5
13.0
19
10
SPF10
NOMESCO Finland
Demanding reparation of dental prosthesis
23.1
13.0
18
8
H66.9
ICD-10 Finland
Otitis media, unspecified
2.4
12.9
94
423
SJC01
NOMESCO Finland
Positioning and fixed attachment of single bracket (Bracket with fixed attachment)
3.9
12.8
39
106
DCD00
NOMESCO Finland
Myringoplasty
12.6
12.7
22
18
SPA20
NOMESCO Finland
Selection and insertion of implant abutment
32.8
12.6
16
5
SPA10
NOMESCO Finland
Setting attachments on tooth or implanted bracket or imblant based structures
+∞
12.5
12
*
SJA01
NOMESCO Finland
Assesment of orthodontic treatment need
24.9
12.5
17
7
SPC20
NOMESCO Finland
Implant borne crown
13.5
12.5
21
16
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
12.0
12.4
22
19
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.5
12.3
44
134
H74.1
ICD-10 Finland
Adhesive middle ear disease
27.3
12.1
16
6
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
11.9
297
2077
SJC03
NOMESCO Finland
Positioning and fixed attachment of brackets, extensive
4.1
11.9
33
84
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
3.0
11.8
54
191
4141
FHL
Myringoplasty (also for reasons other than inflammation)
66.2
11.6
13
*
J01DA08
ATC
[U] cefaclor
2.1
11.6
119
617
Q37.3
ICD-10 Finland
Cleft soft palate with unilateral cleft lip
+∞
11.5
11
*
Q35.70
ICD-10 Finland
Cleft uvula
+∞
11.5
11
*
DFF00
NOMESCO Finland
Pure tone audiometry
2.8
11.4
60
229
H72.2
ICD-10 Finland
Other marginal perforations of tympanic membrane
15.4
11.4
18
12
EB1WA, ,
NOMESCO Finland
13.0
11.2
19
15
SPF20
NOMESCO Finland
Temporary relining of dentures
25.5
11.2
15
6
ZXA10
NOMESCO Finland
Bilateral
2.2
11.0
106
536
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
11.0
161
949
3842A
ICD-9 Finland
Other disorders of tympanic membrane, Perforation of tympanic membrane
44.1
11.0
13
*
SJC40
NOMESCO Finland
Removal of fixed orthodontic appliance with at most 6 brackets
3.3
10.9
41
129
H65.2
ICD-10 Finland
Chronic serous otitis media
5.3
10.9
22
43
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
2.6
10.7
67
280
DLD10
NOMESCO Finland
Reconstruction of cartilage and bone of nose
61.1
10.7
12
*
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
4.9
10.6
23
48
Q35
ICD-10 Finland
Cleft palate
111.8
10.4
11
*
7491A
ICD-9 Finland
Cleft palate and cleft lip, Cleft lip[CHEILOSCHISIS UNILATERALIS COMPLETA]
+∞
10.4
10
*
7491F
ICD-9 Finland
Cleft palate and cleft lip, Cleft lip[CHEILOGNATOSCHISIS UNILATERALIS INCOMPLETA]
+∞
10.4
10
*
SPC40
NOMESCO Finland
Preparation of first or second intermediate attachment tooth for bridge
20.4
9.8
14
7
SJD50
NOMESCO Finland
Placement of prefabricated palatal or lingual arch, dentist-made
10.9
9.8
18
17
SPB10
NOMESCO Finland
Manufacture of a temporary crown to tooth at the dental office
11.6
9.6
17
15
SJX21
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment
3.6
9.5
31
89
SJA03
NOMESCO Finland
Demanding workplan for orthodontic treatment
30.5
9.4
12
*
Q36.0
ICD-10 Finland
Cleft lip, bilateral
+∞
9.4
9
*
EHC30
NOMESCO Finland
Reconstruction of palate
+∞
9.4
9
*
H65.0
ICD-10 Finland
Acute serous otitis media
4.3
9.2
24
58
SJX11
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment, restricted
3.1
9.2
40
137
SPB20
NOMESCO Finland
Temporary bridge
15.9
9.1
14
9
4203
FHL
Mobilization and repositioning of the external pyramid
37.3
9.0
11
*
78159
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Laesio loquendi alia sive NUD
24.4
8.9
12
5
H04
ICPC
Ear discharge
3.9
8.9
26
69
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
10.9
8.8
16
15
SXC03
NOMESCO Finland
Other oral or dental procedure
10.9
8.8
16
15
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.9
8.8
41
147
DLD00
NOMESCO Finland
Reconstruction of cartilage of nose
50.7
8.7
10
*
SJC10
NOMESCO Finland
Orthodontic band in one tooth
3.2
8.7
35
115
H68.1
ICD-10 Finland
Obstruction of Eustachian tube
4.3
8.5
22
53
ZXE20
NOMESCO Finland
More than three and less than five hours
2.2
8.5
75
365
H72.1
ICD-10 Finland
Attic perforation of tympanic membrane
91.2
8.4
9
*
ZXE00
NOMESCO Finland
One hour or less
1.7
8.4
237
1672
Q37.8
ICD-10 Finland
Unspecified cleft palate with bilateral cleft lip
+∞
8.3
8
*
Q35.7
ICD-10 Finland
Cleft uvula
+∞
8.3
8
*
ECB60
NOMESCO Finland
Reconstruction of alveolus
+∞
8.3
8
*
R4130
NOMESCO Finland
Speech therapy
3.6
8.2
27
78
38100
ICD-8 Finland
Otitis media without mention of mastoiditis, Acute
3.3
8.2
30
93
SJB10
NOMESCO Finland
Fitting of removable appliance incl. patient instructions, demanding
4.5
7.9
19
43
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
6.2
7.9
20
33
ZXA05
NOMESCO Finland
Left side
1.9
7.6
107
615
ZZH22
NOMESCO Finland
Graft of patients own bone, block
18.6
7.6
11
6
Z3229
NOMESCO Finland
Other healthcare associate professional
2.4
7.5
53
234
S02CA02
ATC
flumetasone and antiinfectives; otic
3.0
7.5
32
109
R49.2
ICD-10 Finland
Hypernasality and hyponasality
81.0
7.4
8
*
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
7.8
7.4
16
21
SJC00
NOMESCO Finland
Bondable bracket or other fixed attachement
13.6
7.4
12
9
38700
ICD-8 Finland
Other disease of ear and mastoid process, Cholesteatoma of ear
+∞
7.3
7
*
74913
ICD-8 Finland
Cleft palate and cleft lip, Cheilognathoschisis bilateralis
+∞
7.3
7
*
H66
ICD-10 Finland
Suppurative and unspecified otitis media
3.0
7.3
32
111
J34.2
ICD-10 Finland
Deviated nasal septum
2.5
7.2
43
176
K01.0
ICD-10 Finland
Embedded teeth
3.4
7.0
25
76
SPF30
NOMESCO Finland
Relining of denture
8.4
6.9
14
17
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
3.7
6.8
21
58
SPD05
NOMESCO Finland
Mucosa borne complete denture, demanding
40.5
6.8
8
*
38210
ICD-8 Finland
Chronic otitis media with mastoiditis
40.5
6.8
8
*
3821A
ICD-9 Finland
Suppurative and unspecified otitis media, Chronic tubotympanic suppurative otitis media
16.9
6.8
10
6
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
2.8
6.7
33
122
EBA15
NOMESCO Finland
Extraction of multiple teeth
3.3
6.6
24
74
78353
ICD-8 Finland
Symptoms referable to respiratory system, Rhinolia
70.5
6.4
7
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
6.4
347
2802
SPC10
NOMESCO Finland
Standard dental crown
5.6
6.3
17
31
EBA10
NOMESCO Finland
Operative extraction of tooth
1.7
6.3
129
827
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.4
6.3
22
66
4379
FHL
Other measure in this category
+∞
6.3
6
*
4363
FHL
Hidden slit reconstruction
+∞
6.3
6
*
EH1JB
NOMESCO Finland
Functional examination of palate
+∞
6.3
6
*
Q37.2
ICD-10 Finland
Cleft soft palate with bilateral cleft lip
+∞
6.3
6
*
4305
FHL
Tooth extraction by cutting
7.1
6.2
14
20
SPF42
NOMESCO Finland
Repair of dental crown, bridge or implant structure, demanding
27.0
6.2
8
*
K07.30
ICD-10 Finland
Spacing, abnormal of tooth or teeth
2.5
6.2
37
151
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
3.3
6.1
22
68

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Plastic And Reconstructive Surgery
24 [38004467]
—
—
—
1.0e+50
1.0e+50
3.1e+00
3.1e+00
—
—
—
—
—
—
cases:15.52%
controls:0.00%
cases:4.31%
controls:0.00%
cases:9.48%
controls:0.46%
cases:14.91%
controls:0.75%
—
—
—
18
0
98
1100
5
0
111
1100
11
5
105
1093
17
8
97
1060
General Surgery
2 [38004447]
4.8e-02
5.6e-01
—
1.0e+50
2.9e+00
1.9e+00
8.6e-01
cases:16.38%
controls:15.73%
cases:10.34%
controls:6.18%
—
—
cases:22.41%
controls:0.00%
cases:10.34%
controls:0.64%
cases:25.86%
controls:5.19%
cases:30.70%
controls:15.73%
19
173
97
927
12
68
104
1032
—
26
0
90
1100
12
7
104
1093
30
57
86
1041
35
168
79
900
Otolaryngology
4 [38004449]
4.9e-01
1.8e+00
—
1.0e+50
—
1.9e+00
1.3e+00
cases:13.79%
controls:8.91%
cases:16.38%
controls:3.00%
—
—
cases:16.38%
controls:0.00%
—
—
cases:16.38%
controls:2.82%
cases:21.93%
controls:7.30%
16
98
100
1002
19
33
97
1067
—
19
0
97
1100
—
19
31
97
1067
25
78
89
990
Dentistry
C5 [903277]
—
8.9e-01
—
1.0e+50
—
2.4e+00
1.6e+00
—
—
cases:5.17%
controls:2.18%
—
—
cases:13.79%
controls:0.00%
—
—
cases:12.07%
controls:1.28%
cases:11.40%
controls:2.53%
—
6
24
110
1076
—
16
0
100
1100
—
14
14
102
1084
13
27
101
1041
Treatment plan or consultation
WZC00 [2001310885]
1.4e+00
2.3e+00
—
—
—
—
1.6e+00
cases:5.17%
controls:1.36%
cases:5.17%
controls:0.55%
—
—
—
—
—
—
—
—
cases:14.91%
controls:3.37%
6
15
110
1085
6
6
110
1094
—
—
—
—
17
36
97
1032
Inpatient Visit
IP [9201]
1.7e-01
-5.6e-02
-1.0e+50
1.0e+50
2.1e+00
1.3e+00
4.0e-01
cases:16.38%
controls:14.18%
cases:4.31%
controls:4.55%
cases:0.00%
controls:0.55%
cases:18.97%
controls:0.00%
cases:5.17%
controls:0.64%
cases:10.34%
controls:3.01%
cases:7.89%
controls:5.43%
19
156
97
944
5
50
111
1050
0
6
116
1094
22
0
94
1100
6
7
110
1093
12
33
104
1065
9
58
105
1010
Outpatient Visit
OP [9202]
2.4e-01
4.7e-01
4.6e-01
—
1.9e+00
1.2e+00
4.6e-01
cases:49.14%
controls:43.09%
cases:40.52%
controls:29.82%
cases:10.34%
controls:6.82%
—
—
cases:29.31%
controls:6.09%
cases:58.62%
controls:29.42%
cases:64.91%
controls:53.93%
57
474
59
626
47
328
69
772
12
75
104
1025
—
34
67
82
1033
68
323
48
775
74
576
40
492
Oral Surgery
19 [38004464]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:5.26%
controls:0.47%
—
—
—
—
—
—
6
5
108
1063
Dental impressions
SBB10 [2001310299]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:10.53%
controls:1.22%
—
—
—
—
—
—
12
13
102
1055
Outpatient Hospital
22 [8756]
9.6e-03
2.6e-01
—
—
—
1.3e+00
7.4e-01
cases:18.97%
controls:18.82%
cases:7.76%
controls:6.09%
—
—
—
—
—
—
cases:15.52%
controls:4.83%
cases:32.46%
controls:18.63%
22
207
94
893
9
67
107
1033
—
—
—
18
53
98
1045
37
199
77
869
cefalexin; oral
J01DB01 [21602870]
3.7e-01
4.6e-01
—
—
—
8.4e-01
8.7e-01
cases:23.28%
controls:17.27%
cases:9.48%
controls:6.18%
—
—
—
—
—
—
cases:12.93%
controls:6.01%
cases:39.47%
controls:21.54%
27
190
89
910
11
68
105
1032
—
—
—
15
66
101
1032
45
230
69
838
hydrochlorothiazide and potassium-sparing agents
C03EA01 [21601543]
-1.0e+50
-1.0e+50
—
—
-1.0e+50
—
—
cases:0.00%
controls:1.64%
cases:0.00%
controls:1.27%
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
—
0
18
116
1082
0
14
116
1086
—
—
0
6
116
1094
—
—
Operative extraction of tooth
EBA10 [2001301925]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
Removal of sutures
SPAT1153 [2001700254]
—
—
—
—
—
—
1.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:5.26%
controls:1.69%
—
—
—
—
—
—
6
18
108
1050
tizanidine; oral
M03BX02 [21604116]
-1.7e-01
—
—
—
—
8.1e-01
2.3e-01
cases:6.03%
controls:7.09%
—
—
—
—
—
—
—
—
cases:5.17%
controls:2.37%
cases:12.28%
controls:10.02%
7
78
109
1022
—
—
—
—
6
26
110
1072
14
107
100
961
Chronic rhinitis
J31.0 [45572165]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
ezetimibe; oral
C10AX09 [21601896]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
7
114
1061
Fever, unspecified
R50.9 [45582716]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.82%
—
—
—
—
—
—
—
—
—
—
—
0
9
116
1091
—
—
—
—
—
Unspecified haematuria
R31 [45553726]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
0
6
116
1094
—
—
—
—
—
0
5
114
1063
SMOKING - SMOKE2: no - SMOKE3: former - SMOKE5: former
SMOKING-2-2-4 [2002330109]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:1.91%
cases:0.00%
controls:1.09%
—
—
—
—
—
—
—
—
—
—
0
21
116
1079
0
12
116
1088
—
—
—
—
—
Cesarean section
8811 [2000101397]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
atorvastatin; oral
C10AA05 [21601860]
—
—
—
—
—
—
8.2e-02
—
—
—
—
—
—
—
—
—
—
—
—
cases:5.26%
controls:4.87%
—
—
—
—
—
—
6
52
108
1016
Cellulitis of finger and toe
L03.0 [45557691]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
7
114
1061
mometasone; nasal
R01AD09 [21605051]
4.0e-01
9.4e-01
—
—
—
7.0e-01
2.7e-01
cases:6.90%
controls:4.73%
cases:5.17%
controls:2.09%
—
—
—
—
—
—
cases:4.31%
controls:2.19%
cases:10.53%
controls:8.24%
8
52
108
1048
6
23
110
1077
—
—
—
5
24
111
1074
12
88
102
980
Bacteria identified in Isolate by Culture
43409-2 [3042936]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
Oncology Clinic/Center
261QX0200X [38004268]
7.4e-01
—
—
—
—
-1.0e+50
—
cases:5.17%
controls:2.55%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
6
28
110
1072
—
—
—
—
0
5
116
1093
—
Cleft palate and cleft lip, Cleft palate[PALATOSCHISIS COMPLETA]
7490A [2000406404]
—
—
—
1.0e+50
—
—
—
—
—
—
—
—
—
cases:4.31%
controls:0.00%
—
—
—
—
—
—
—
—
—
5
0
111
1100
—
—
—
hydrocortisone and antiinfectives
S03CA04 [21605208]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.39%
controls:1.03%
—
—
—
—
—
—
5
11
109
1057
More than three and less than five hours
ZXE20 [2001311408]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
0
5
116
1095
—
—
—
—
—
0
5
114
1063
etoricoxib; oral
M01AH05 [21603996]
—
—
-1.0e+50
—
—
—
2.0e-01
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
cases:7.89%
controls:6.55%
—
—
0
5
116
1095
—
—
—
9
70
105
998
econazole
D01AC03 [21601922]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
116
1094
—
—
—
—
—
—
Zoster [herpes zoster]
B02 [45552205]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
6
114
1062
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
—
5.5e-02
—
—
-1.0e+50
6.5e-01
-8.3e-02
—
—
cases:4.31%
controls:4.09%
—
—
—
—
cases:0.00%
controls:0.73%
cases:6.90%
controls:3.73%
cases:11.40%
controls:12.27%
—
5
45
111
1055
—
—
0
8
116
1092
8
41
108
1057
13
131
101
937
Telephone prescription or other care instructions
WZB00 [2001310884]
—
-1.0e+50
—
—
—
—
6.1e-01
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
cases:4.39%
controls:2.43%
—
0
5
116
1095
—
—
—
—
5
26
109
1042
Need for immunization against influenza
Z25.1 [45581017]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
Epicardial ultrasonography
XFE00 [2001303343]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.82%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
116
1091
—
—
—
—
—
—
Acute tubulo-interstitial nephritis
N10 [45543856]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.91%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
0
10
116
1090
—
—
—
—
0
5
116
1093
—
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
—
—
—
—
—
—
4.2e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.14%
controls:4.12%
—
—
—
—
—
—
7
44
107
1024
tranexamic acid; oral, parenteral
B02AA02 [21601036]
-1.0e+50
—
—
—
—
-1.0e+50
1.1e+00
cases:0.00%
controls:1.09%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.55%
cases:4.39%
controls:1.50%
0
12
116
1088
—
—
—
—
0
6
116
1092
5
16
109
1052
Lumbar puncture
TAB00 [2001300538]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
0
6
116
1094
—
—
—
—
0
5
114
1063
Exploration of knee joint, arthroscopic
NGA30 [2001308091]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
116
1094
—
—
—
—
—
—
Rectal ultrasound examination of prostate
KE1BE [2001306106]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
6
114
1062
Person consulting for explanation of investigation findings
Z71.2 [45552100]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.69%
—
0
6
116
1094
—
—
—
—
0
18
114
1050
Diabetes, insulin-treated
103 [2001600103]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:6.27%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
0
69
116
1031
—
—
—
—
0
6
116
1092
—
carbamazepine; oral, rectal
N03AF01 [21604417]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
encephalitis, tick borne, inactivated, whole virus
J07BA01 [21601331]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
Thyroid insufficiency
104 [2001600104]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
7
114
1061
Teaching
WZC30 [2001310891]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.94%
—
—
—
—
—
—
0
10
114
1058
ethylmorphine; oral
R05DA01 [21603397]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
0
5
116
1093
—
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
F70.0 [45595920]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
Limited function/disability (L)
L28 [2002000647]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
7
114
1061
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
Prick test
37968009 [4242723]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
6
114
1062
Orthopedic Surgery
20 [38004465]
3.4e-01
-1.0e+50
—
—
-1.0e+50
—
2.7e-01
cases:6.03%
controls:4.36%
cases:0.00%
controls:1.91%
—
—
—
—
cases:0.00%
controls:0.45%
—
—
cases:10.53%
controls:8.24%
7
48
109
1052
0
21
116
1079
—
—
0
5
116
1095
—
12
88
102
980
Acute maxillary sinusitis
J01.0 [45601112]
-1.0e+50
—
—
—
—
—
8.8e-01
cases:0.00%
controls:0.82%
—
—
—
—
—
—
—
—
—
—
cases:4.39%
controls:1.87%
0
9
116
1091
—
—
—
—
—
5
20
109
1048
Excessive and frequent menstruation with regular cycle
N92.0 [45577544]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.75%
—
—
—
—
—
—
0
8
114
1060
Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6357-8 [3024950]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.73%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
0
8
116
1092
—
—
—
—
0
5
116
1093
—
verapamil; oral, parenteral
C08DA01 [21601767]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.64%
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
0
7
116
1093
0
5
116
1095
—
—
—
—
—
loperamide; oral
A07DA03 [21600646]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
6
114
1062
Sprain and strain of ankle
S93.4 [45550848]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
7
114
1061
drospirenone and ethinylestradiol
G03AA12 [21602485]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.84%
0
5
116
1095
—
—
—
—
—
0
9
114
1059
Excessive and frequent menstruation with irregular cycle
N92.1 [45539073]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
—
—
—
—
—
—
1.1e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.39%
controls:3.93%
—
—
—
—
—
—
5
42
109
1026
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
206 [2001600204]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
0
5
116
1093
—
Aid fitting and borrowing and monitoring of use
SPAT1230 [2001700331]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
7
114
1061
Leukocytes [#/volume] in Urine
30405-5 [3018095]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.27%
—
—
—
—
—
—
—
—
—
—
—
—
0
14
116
1086
—
—
—
—
—
—
Periodontitis complex
K05.30 [2000502728]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
Delivery by emergency caesarean section
O82.10 [2000503217]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.73%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
116
1092
—
—
—
—
—
—
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
116
1093
—
—
—
—
—
—
dextromethorphan, combinations; oral
N07XX59 [43534835]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
0
7
116
1091
—
insulin degludec; parenteral
A10AE06 [43534747]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
epinephrine; parenteral
C01CA24 [21600303]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
0
9
114
1059
MCH [Entitic mass]
28539-5 [3035941]
—
3.2e-01
—
—
—
6.4e-01
-6.0e-02
—
—
cases:6.03%
controls:4.45%
—
—
—
—
—
—
cases:8.62%
controls:4.74%
cases:13.16%
controls:13.86%
—
7
49
109
1051
—
—
—
10
52
106
1046
15
148
99
920
Inpatient Hospital
21 [8717]
1.9e-01
1.4e-01
—
1.0e+50
—
8.8e-01
4.1e-01
cases:30.17%
controls:26.27%
cases:10.34%
controls:9.09%
—
—
cases:9.48%
controls:0.00%
—
—
cases:17.24%
controls:7.92%
cases:35.09%
controls:26.40%
35
289
81
811
12
100
104
1000
—
11
0
105
1100
—
20
87
96
1011
40
282
74
786
Other and unspecified convulsions
R56.8 [45602033]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
116
1094
—
—
—
—
—
—
Other and unspecified skin changes
R23.8 [45573020]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.03%
—
—
—
—
—
—
0
11
114
1057
astemizole; oral
R06AX11 [21603512]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
Rheumatology
66 [38004491]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.39%
controls:0.94%
—
—
—
—
—
—
5
10
109
1058
SMOKING - SMOKE2: yes - SMOKE3: current - SMOKE5: Unspecified
SMOKING-1-1-0 [2002330116]
—
—
-1.0e+50
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
0
7
116
1093
—
—
—
—
Cathetrisation of vein
TPH04 [2001309597]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
12
116
1088
—
—
—
—
—
—
Migraine with aura [classical migraine]
G43.1 [45562086]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
116
1094
—
—
—
—
—
—
Sytologyspecimen from mouth of uterus
XLD00 [2001306651]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
116
1094
—
—
—
—
—
—
Chondromalacia patellae
M22.4 [45538712]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
oxycodone and naloxone; oral
N02AA55 [21604265]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
cough suppressants and expectorants
R05FB02 [21603442]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
0
7
116
1091
—
Ultrasound screening of fetal nuchal translucency
MA2JE [2001306837]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
7
114
1061
Consultation of another employee
SPAT1260 [2001700361]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.75%
—
—
—
—
—
—
0
8
114
1060
Other disturbance in the tooth eruption
K00.68 [2000502648]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
6
114
1062
Routine postpartum follow-up
Z39.2 [45547306]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
0
9
114
1059
No procedures
SPAT1301 [2001700402]
—
-1.0e+50
—
—
—
-1.0e+50
6.5e-01
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
cases:0.00%
controls:1.28%
cases:4.39%
controls:2.34%
—
0
6
116
1094
—
—
—
0
14
116
1084
5
25
109
1043
amoxicillin; oral, parenteral
J01CA04 [21602823]
2.5e-01
8.2e-01
—
—
-1.0e+50
5.3e-01
3.9e-01
cases:25.86%
controls:21.36%
cases:14.66%
controls:7.00%
—
—
—
—
cases:0.00%
controls:0.73%
cases:11.21%
controls:6.92%
cases:29.82%
controls:22.38%
30
235
86
865
17
77
99
1023
—
—
0
8
116
1092
13
76
103
1022
34
239
80
829
folic acid
V04CX02 [715877]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
7
114
1061
tetanus toxoid, combinations with diphtheria toxoid
J07AM51 [21601317]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
0
9
114
1059
Gynaecological examination (general)(routine)
Z01.4 [45542395]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
116
1093
—
—
—
—
—
—
enalapril; oral, parenteral
C09AA02 [21601786]
—
-1.0e+50
—
—
-1.0e+50
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:1.64%
—
—
—
—
cases:0.00%
controls:0.55%
cases:0.00%
controls:1.73%
cases:0.00%
controls:2.53%
—
0
18
116
1082
—
—
0
6
116
1094
0
19
116
1079
0
27
114
1041
phenoxymethylpenicillin; oral
J01CE02 [21602842]
3.3e-01
1.2e+00
-1.0e+50
—
—
1.2e+00
-1.0e-01
cases:13.79%
controls:10.27%
cases:8.62%
controls:2.82%
cases:0.00%
controls:0.45%
—
—
—
—
cases:7.76%
controls:2.46%
cases:11.40%
controls:12.45%
16
113
100
987
10
31
106
1069
0
5
116
1095
—
—
9
27
107
1071
13
133
101
935
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 [3009035]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.82%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
0
9
116
1091
—
—
—
—
0
5
116
1093
—
Separate planning of oral and dental treatment, standard
SAC01 [2001310283]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
6
114
1062
insulin aspart; parenteral
A10AB05 [21600719]
—
—
-1.0e+50
—
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
cases:0.00%
controls:0.64%
cases:0.00%
controls:2.37%
—
—
—
—
0
6
116
1094
—
0
7
116
1093
0
26
116
1072
—
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:2.00%
—
—
—
—
—
—
—
—
—
—
—
—
0
22
116
1078
—
—
—
—
—
—
norethisterone and ethinylestradiol
G03AA05 [21602478]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
—
0
7
116
1093
—
—
—
—
—
Vaccination
SPAT1325 [2001700426]
—
—
—
—
—
—
1.9e-02
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.39%
controls:4.31%
—
—
—
—
—
—
5
46
109
1022
desogestrel
G03AC09 [21602505]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
116
1094
—
—
—
—
—
—
oxybutynin; oral, transdermal
G04BD04 [21602637]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
0
7
116
1093
—
—
—
0
6
116
1092
—
Other hypothyroidism
E03 [45581337]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.75%
—
—
—
—
—
—
0
8
114
1060
long-acting sulfonamides - combinations
J01ED20 [21602959]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
0
5
116
1093
—
Astigmatism
H52.2 [45547934]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
6
114
1062
Obstetrics / Gynecology
16 [38004461]
-1.4e-01
9.5e-02
—
—
—
2.9e-01
2.8e-01
cases:11.21%
controls:12.73%
cases:5.17%
controls:4.73%
—
—
—
—
—
—
cases:5.17%
controls:3.92%
cases:13.16%
controls:10.30%
13
140
103
960
6
52
110
1048
—
—
—
6
43
110
1055
15
110
99
958
Sterilization
Z30.2 [45609921]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
116
1094
—
—
—
—
—
—
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.82%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
116
1091
—
—
—
—
—
—
celecoxib
L01XX33 [21603805]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
—
0
6
116
1094
—
—
—
—
—
amitriptyline and psycholeptics
N06CA01 [21604789]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.75%
—
—
—
—
—
—
0
8
114
1060
Diabetes insulin dependent
T89 [2002001130]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.55%
cases:0.00%
controls:0.55%
—
—
—
—
—
—
cases:0.00%
controls:0.82%
cases:0.00%
controls:1.31%
0
6
116
1094
0
6
116
1094
—
—
—
0
9
116
1089
0
14
114
1054
other antifungals for topical use - combinations; ointment
D01AE20 [21601959]
—
—
—
—
—
-1.0e+50
8.8e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.55%
cases:4.39%
controls:1.87%
—
—
—
—
—
0
6
116
1092
5
20
109
1048
Respiratory infection other
R83 [2002000951]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.73%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.94%
0
8
116
1092
—
—
—
—
—
0
10
114
1058
Malignant neoplasm of prostate
C61 [45547509]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
cases:0.00%
controls:0.56%
—
—
—
—
—
0
5
116
1093
0
6
114
1062
Viral infection, unspecified
B34.9 [45605229]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
116
1094
—
—
—
—
—
—
pivmecillinam; oral
J01CA08 [21602827]
—
—
—
—
—
—
9.3e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:12.28%
controls:5.24%
—
—
—
—
—
—
14
56
100
1012
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
G40.29 [2000502142]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
diphenhydramine, combinations
R06AA52 [21603454]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
0
5
116
1093
—
Foot/toe symptom/complaint
L17 [2002000641]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.59%
—
—
—
—
—
—
0
17
114
1051
hydrocortisone aceponate
D07AC16 [21602135]
—
—
-1.0e+50
—
—
-1.0e+50
6.9e-01
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
cases:0.00%
controls:1.82%
cases:11.40%
controls:6.09%
—
—
0
5
116
1095
—
—
0
20
116
1078
13
65
101
1003
SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: never
SMOKING-2-3-5 [2002330114]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:2.00%
—
—
—
—
—
—
—
—
—
—
—
0
22
116
1078
—
—
—
—
—
folic acid; oral, parenteral
B03BB01 [21601129]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
7
114
1061
Spinal stenosis
M48.0 [45557888]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
6
114
1062
chlorhexidine
D09AA12 [21602275]
—
—
—
—
—
-1.0e+50
8.8e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.55%
cases:4.39%
controls:1.87%
—
—
—
—
—
0
6
116
1092
5
20
109
1048
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:1.18%
cases:0.00%
controls:0.73%
—
—
—
—
—
—
—
—
—
—
0
13
116
1087
0
8
116
1092
—
—
—
—
—
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
LC2BE [2001306544]
—
-1.0e+50
—
—
—
—
1.3e+00
—
—
cases:0.00%
controls:0.73%
—
—
—
—
—
—
—
—
cases:4.39%
controls:1.22%
—
0
8
116
1092
—
—
—
—
5
13
109
1055
Hypothyroidism, unspecified
E03.9 [45537945]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
7
114
1061
chlorhexidine
S02AA09 [21605155]
—
—
—
—
—
-1.0e+50
8.8e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.55%
cases:4.39%
controls:1.87%
—
—
—
—
—
0
6
116
1092
5
20
109
1048
Suture or treatment of traumatic wound
SPAT1149 [2001700250]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
7
114
1061
lisinopril; oral
C09AA03 [21601787]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.73%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
116
1092
—
—
—
—
—
—
Albumin [Mass/volume] in Urine
1754-1 [3012516]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.82%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
116
1091
—
—
—
—
—
—
Planned health check-up monitoring, health check-up performed based on individual need
SPAT1317 [2001700418]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
0
7
116
1091
—
methylphenidate; oral
N06BA04 [21604757]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
7
114
1061
Single live birth
Z37.0 [45571346]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
—
0
6
116
1094
—
—
—
—
—
Streptococcus pyogenes Ag [Presence] in Throat
18481-2 [3033319]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.82%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
116
1091
—
—
—
—
—
—
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.82%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
116
1091
—
—
—
—
—
—
ticagrelor; oral
B01AC24 [40252640]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
8.4e-01
—
—
—
—
—
3.3e-01
cases:6.90%
controls:3.09%
—
—
—
—
—
—
—
—
—
—
cases:7.89%
controls:5.81%
8
34
108
1066
—
—
—
—
—
9
62
105
1006
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
—
2.6e-01
—
—
-1.0e+50
—
6.5e-02
—
—
cases:4.31%
controls:3.36%
—
—
—
—
cases:0.00%
controls:0.82%
—
—
cases:11.40%
controls:10.77%
—
5
37
111
1063
—
—
0
9
116
1091
—
13
115
101
953
Epilepsy
G40 [45595935]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
0
5
116
1095
—
—
—
—
—
0
5
114
1063
Implantation of vascular injection port
TPX10 [2001309608]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
116
1094
—
—
—
—
—
—
Pain localized to other parts of lower abdomen
R10.3 [45534426]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.91%
—
—
—
—
—
—
—
—
—
—
—
—
0
10
116
1090
—
—
—
—
—
—
Cervicobrachial syndrome
M53.1 [45567577]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
Application of soft bandage
SPAT1211 [2001700312]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
misoprostol; oral
A02BB01 [21600093]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
116
1094
—
—
—
—
—
—
dexchlorpheniramine, combinations
R06AB52 [21603467]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
7
114
1061
betamethasone
D07AC01 [21602120]
5.1e-01
—
—
—
—
—
6.9e-01
cases:5.17%
controls:3.18%
—
—
—
—
—
—
—
—
—
—
cases:6.14%
controls:3.18%
6
35
110
1065
—
—
—
—
—
7
34
107
1034
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
116
1094
—
—
—
—
—
—
Emergency Medicine
93 [38004510]
—
—
—
—
—
-1.0e+50
4.0e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.28%
cases:6.14%
controls:4.21%
—
—
—
—
—
0
14
116
1084
7
45
107
1023
fluticasone furoate; nasal
R01AD12 [21605053]
7.3e-01
—
—
—
—
1.1e+00
8.6e-01
cases:6.90%
controls:3.45%
—
—
—
—
—
—
—
—
cases:5.17%
controls:1.82%
cases:12.28%
controls:5.62%
8
38
108
1062
—
—
—
—
6
20
110
1078
14
60
100
1008
Cardiology
6 [38004451]
—
—
—
—
—
—
9.2e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.14%
controls:2.53%
—
—
—
—
—
—
7
27
107
1041
cefaclor; oral
J01DC04 [21602886]
8.4e-01
—
—
—
—
—
—
cases:4.31%
controls:1.91%
—
—
—
—
—
—
—
—
—
—
—
—
5
21
111
1079
—
—
—
—
—
—
Recording of ECG
SPAT1097 [2001700198]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
7
114
1061
One-surface restoration
SFA10 [2001310358]
—
—
—
—
—
—
5.0e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:11.40%
controls:7.21%
—
—
—
—
—
—
13
77
101
991
Pediatric Nephrology
OMOP4822026 [45756813]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.73%
cases:0.00%
controls:0.64%
—
—
—
—
—
—
cases:0.00%
controls:0.55%
cases:0.00%
controls:0.94%
0
8
116
1092
0
7
116
1093
—
—
—
0
6
116
1092
0
10
114
1058
norfloxacin; oral
J01MA06 [21603013]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
—
0
6
116
1094
—
—
—
—
—
Nutritional therapy
R4190 [2001310243]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.75%
—
—
—
—
—
—
0
8
114
1060
Heart failure
I50 [45581779]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
Other specified counselling
Z71.8 [45581061]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.91%
—
—
—
—
—
—
—
—
—
—
—
—
0
10
116
1090
—
—
—
—
—
—
naproxen; oral, rectal
M01AE02 [21603968]
3.3e-01
—
—
—
-1.0e+50
1.0e+00
6.2e-01
cases:12.07%
controls:9.00%
—
—
—
—
—
—
cases:0.00%
controls:0.45%
cases:6.03%
controls:2.28%
cases:15.79%
controls:9.18%
14
99
102
1001
—
—
—
0
5
116
1095
7
25
109
1073
18
98
96
970
diclofenac
D11AX18 [21602355]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
Loss of teeth due to accident, extraction or local periodontal disease
K08.1 [45591573]
—
—
—
—
—
1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:4.31%
controls:0.00%
—
—
—
—
—
—
—
5
0
111
1098
—
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
116
1094
—
—
—
—
—
—
montelukast; oral
R03DC03 [21603356]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
cases:0.00%
controls:0.91%
—
—
—
0
5
116
1095
—
—
—
0
10
116
1088
—
Celiac disease serology panel - Serum
94494-2 [36660697]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
pneumococcus, purified polysaccharides antigen conjugated
J07AL02 [21601313]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
7
114
1061
Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
12841-3 [3001784]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
0
5
116
1093
—
Arthrocentesis, unspecified region, unspecified region
TNX10 [2001308560]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
Fever
A03 [2002000144]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
—
0
6
116
1094
—
—
—
—
—
Essential (primary) hypertension
I10 [45591453]
—
—
—
—
—
—
-1.4e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:5.26%
controls:5.99%
—
—
—
—
—
—
6
64
108
1004
hydroxyzine; oral, parenteral
N05BB01 [21604590]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
—
0
6
116
1094
—
—
—
—
—
Ultrasound measurement of residual urine
KC1EE [2001305918]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.75%
—
—
—
—
—
—
0
8
114
1060
Clinical photography of mouth and teeth
SBB00 [2001310298]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.39%
controls:0.66%
—
—
—
—
—
—
5
7
109
1061
Ophthalmology
18 [38004463]
-1.4e-01
—
—
—
-1.0e+50
5.7e-01
-4.7e-01
cases:6.03%
controls:6.91%
—
—
—
—
—
—
cases:0.00%
controls:0.45%
cases:6.90%
controls:4.01%
cases:7.02%
controls:10.77%
7
76
109
1024
—
—
—
0
5
116
1095
8
44
108
1054
8
115
106
953
brinzolamide, combinations
S01EC54 [45893490]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
sertraline; oral
N06AB06 [21604714]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.94%
—
—
—
—
—
—
0
10
114
1058
pH of Serum or Plasma
2753-2 [3018418]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:1.00%
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.84%
0
11
116
1089
0
5
116
1095
—
—
—
—
0
9
114
1059
clidinium and psycholeptics
A03CA02 [21600204]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
hydrocortisone and antiinfectives
S02CA03 [21605175]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.39%
controls:1.03%
—
—
—
—
—
—
5
11
109
1057
Observation for other suspected cardiovascular diseases
Z03.5 [45590692]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
0
5
116
1095
—
—
—
—
—
0
7
114
1061
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
rabeprazole; oral
A02BC04 [21600099]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
Fall on same level involving ice and snow
W00 [45756242]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
6
114
1062
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
—
2.6e-01
—
—
-1.0e+50
—
7.4e-02
—
—
cases:4.31%
controls:3.36%
—
—
—
—
cases:0.00%
controls:0.82%
—
—
cases:11.40%
controls:10.67%
—
5
37
111
1063
—
—
0
9
116
1091
—
13
114
101
954
Intestinal infections due to other organisms, Other organism, not elsewhere classified
0088X [2000400186]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
116
1094
—
—
—
—
—
—
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
General anaesthesia
WX402 [2001310806]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:1.00%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
0
11
116
1089
—
—
—
—
—
0
5
114
1063
Fracture of lateral malleolus
S82.6 [45569819]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
7
114
1061
Thorax X-ray examination
GD1AA [2001303617]
—
-1.0e+50
—
—
—
—
1.3e+00
—
—
cases:0.00%
controls:1.09%
—
—
—
—
—
—
—
—
cases:7.89%
controls:2.25%
—
0
12
116
1088
—
—
—
—
9
24
105
1044
combinations of corticosteroids
D07XB30 [21602188]
4.3e-01
—
—
—
—
—
3.1e-01
cases:9.48%
controls:6.36%
—
—
—
—
—
—
—
—
—
—
cases:10.53%
controls:7.96%
11
70
105
1030
—
—
—
—
—
12
85
102
983
pantoprazole; oral, parenteral
A02BC02 [21600097]
—
6.6e-01
—
—
-1.0e+50
9.9e-01
6.6e-01
—
—
cases:5.17%
controls:2.73%
—
—
—
—
cases:0.00%
controls:0.64%
cases:4.31%
controls:1.64%
cases:10.53%
controls:5.71%
—
6
30
110
1070
—
—
0
7
116
1093
5
18
111
1080
12
61
102
1007
Photography of fundus of eye
XCK10 [2001301381]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.82%
cases:0.00%
controls:1.50%
—
—
—
—
—
0
9
116
1089
0
16
114
1052
zopiclone; oral
N05CF01 [21604654]
—
—
—
—
—
—
6.5e-02
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.39%
controls:4.12%
—
—
—
—
—
—
5
44
109
1024
Cystoscopy
UKC02 [2001306005]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.94%
—
—
—
—
—
—
0
10
114
1058
Dental calculus supragingival
K03.64 [2000502689]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:1.36%
cases:0.00%
controls:0.64%
—
—
—
—
—
—
cases:0.00%
controls:0.73%
—
—
0
15
116
1085
0
7
116
1093
—
—
—
0
8
116
1090
—
Emergency visit or other similar visit involving procedures
WYA05 [2001310871]
—
-1.0e+50
—
—
—
-1.0e+50
4.0e-03
—
—
cases:0.00%
controls:1.36%
—
—
—
—
—
—
cases:0.00%
controls:1.09%
cases:5.26%
controls:5.24%
—
0
15
116
1085
—
—
—
0
12
116
1086
6
56
108
1012
Colonoscopy Study observation
28023-0 [3022145]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
phenylephrine, combinations
R01BA53 [21603214]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
0
7
116
1091
—
Insulin glargine 300 U / ml
177 [2001600176]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
paracetamol, combinations excl. psycholeptics
N02BE51 [21604348]
5.4e-01
—
—
—
—
-1.0e+50
—
cases:5.17%
controls:3.09%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
6
34
110
1066
—
—
—
—
0
6
116
1092
—
azelastine; nasal
R01AC03 [21605035]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
0
5
116
1095
—
—
—
0
6
116
1092
—
hydroxychloroquine; oral
P01BA02 [21604889]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
Upper respiratory infection acute
R74 [2002000942]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
cases:0.00%
controls:0.73%
—
—
—
0
5
116
1095
—
—
—
0
8
116
1090
—
Assessment of need for oral health care, standard
SAD01 [2001310287]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.31%
—
—
—
—
—
—
0
14
114
1054
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
116
1094
—
—
—
—
—
—
Psychiatry
26 [38004469]
9.7e-01
—
—
—
—
—
5.7e-01
cases:6.03%
controls:2.36%
—
—
—
—
—
—
—
—
—
—
cases:4.39%
controls:2.53%
7
26
109
1074
—
—
—
—
—
5
27
109
1041
nimesulide; oral
M01AX17 [21604007]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:1.91%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.82%
—
—
0
21
116
1079
—
—
—
—
0
9
116
1089
—
insulin (human); parenteral
A10AD01 [21600729]
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.36%
—
—
—
—
—
—
—
—
0
15
116
1085
—
—
Cleft lip, unilateral
Q36.9 [45597123]
—
—
—
1.0e+50
—
—
—
—
—
—
—
—
—
cases:5.17%
controls:0.00%
—
—
—
—
—
—
—
—
—
6
0
110
1100
—
—
—
isotretinoin; oral
D10BA01 [21602320]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
hydrocortisone buteprate
D07AB11 [21602115]
—
—
-1.0e+50
—
—
-1.0e+50
6.9e-01
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
cases:0.00%
controls:1.82%
cases:11.40%
controls:6.09%
—
—
0
5
116
1095
—
—
0
20
116
1078
13
65
101
1003
glucagon; nasal, parenteral
H04AA01 [21602778]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:3.27%
cases:0.00%
controls:1.18%
—
—
—
—
—
—
cases:0.00%
controls:1.55%
cases:0.00%
controls:5.24%
0
36
116
1064
0
13
116
1087
—
—
—
0
17
116
1081
0
56
114
1012
Appendectomy
JEA00 [2001304802]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
0
5
116
1095
—
—
—
—
—
0
6
114
1062
diclofenac; ointment
M02AA15 [21604051]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
Guidance concerning treatment of rash and skin
SPAT1156 [2001700257]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
6
114
1062
ofloxacin; oral, parenteral
J01MA01 [21603008]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.82%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
116
1091
—
—
—
—
—
—
Dermatitis due to ingested food
L27.2 [45596371]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
116
1093
—
—
—
—
—
—
insulin (beef); parenteral
A10AD02 [21600730]
-1.0e+50
-1.0e+50
—
—
-1.0e+50
-1.0e+50
—
cases:0.00%
controls:1.91%
cases:0.00%
controls:1.55%
—
—
—
—
cases:0.00%
controls:0.55%
cases:0.00%
controls:1.91%
—
—
0
21
116
1079
0
17
116
1083
—
—
0
6
116
1094
0
21
116
1077
—
sulfasalazine; oral, rectal
A07EC01 [21600663]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.64%
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.75%
0
7
116
1093
0
5
116
1095
—
—
—
—
0
8
114
1060
Osmolality of Urine
2695-5 [3026782]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
116
1093
—
—
—
—
—
—
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
117 [2001600117]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.73%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
116
1092
—
—
—
—
—
—
Periodontal treatment, very brief
SDA01 [2001310326]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:1.55%
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
0
17
116
1083
0
6
116
1094
—
—
—
—
—
Fractional scraping
8113 [2000101291]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
1.8e-01
—
—
—
—
—
5.9e-01
cases:6.03%
controls:5.09%
—
—
—
—
—
—
—
—
—
—
cases:7.02%
controls:4.03%
7
56
109
1044
—
—
—
—
—
8
43
106
1025
Pharmacologic abortion
LCH11 [2001306623]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
Bacteria identified in Blood by Culture
600-7 [3023368]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
piroxicam; oral, parenteral, rectal
M01AC01 [21603961]
2.9e-01
—
—
—
—
—
—
cases:5.17%
controls:3.91%
—
—
—
—
—
—
—
—
—
—
—
—
6
43
110
1057
—
—
—
—
—
—
Insertion of intrauterine device
TLC00 [2001306647]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
6
114
1062
C reactive protein [Mass/volume] in Capillary blood
48421-2 [3051387]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
6
114
1062
amlodipine; oral
C08CA01 [21601747]
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
0
6
116
1094
—
—
Nontoxic multinodular goitre
E04.2 [45576425]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
116
1094
—
—
—
—
—
—
Predominantly allergic asthma
J45.0 [45557624]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.09%
—
—
—
—
—
—
—
0
12
116
1086
—
Hearing complaint
H02 [2002000476]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
7
114
1061
Observation for other suspected diseases and conditions
Z03.89 [2000503757]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.22%
—
—
—
—
—
—
0
13
114
1055
Laceration/cut
S18 [2002000983]
—
—
—
—
—
—
4.0e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.39%
controls:3.00%
—
—
—
—
—
—
5
32
109
1036
Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
21416-3 [3003510]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
0
7
116
1093
—
—
—
—
0
5
116
1093
—
digoxin; oral, parenteral
C01AA05 [21600234]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.55%
cases:0.00%
controls:0.45%
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
0
6
116
1094
0
5
116
1095
—
—
—
0
5
116
1093
—
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
116
1093
—
—
—
—
—
—
Follow-up examination after surgery for other conditions
Z09.0 [45576131]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
prednisolone
A07EA01 [21600653]
7.0e-01
—
—
—
—
1.2e+00
4.7e-01
cases:6.03%
controls:3.09%
—
—
—
—
—
—
—
—
cases:4.31%
controls:1.28%
cases:7.02%
controls:4.49%
7
34
109
1066
—
—
—
—
5
14
111
1084
8
48
106
1020
lymecycline; oral, parenteral
J01AA04 [21602802]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.82%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
116
1091
—
—
—
—
—
—
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
116
1093
—
—
—
—
—
—
doxepin; oral, parenteral
N06AA12 [21604699]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
116
1094
—
—
—
—
—
—
Rehabilitation Hospital
283X00000X [38004285]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]
8.3e-01
—
—
—
—
-1.0e+50
1.1e-01
cases:6.03%
controls:2.73%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.73%
cases:4.39%
controls:3.93%
7
30
109
1070
—
—
—
—
0
8
116
1090
5
42
109
1026
Contraception oral
W11 [2002001211]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
116
1094
—
—
—
—
—
—
Emergency treatment
SGA01 [2001310379]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.00%
—
—
—
—
—
—
—
—
—
—
—
—
0
11
116
1089
—
—
—
—
—
—
Treatment of a patient needing special arrangements
WYA30 [2001310874]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
7
114
1061
mesalazine; oral, rectal
A07EC02 [21600664]
-1.0e+50
—
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
cases:0.00%
controls:0.47%
0
5
116
1095
—
—
—
—
0
5
116
1093
0
5
114
1063
Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
546-2 [3024135]
-1.0e+50
-1.0e+50
—
—
—
—
1.2e+00
cases:0.00%
controls:1.00%
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
cases:6.14%
controls:1.97%
0
11
116
1089
0
5
116
1095
—
—
—
—
7
21
107
1047
Removal of fixed intravenous catheter
TPH90 [2001309607]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.82%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
116
1091
—
—
—
—
—
—
Hand/finger symptom/complaint
L12 [2002000636]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.75%
—
—
—
—
—
—
0
8
114
1060
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
hydrocortisone
D07XA01 [21602180]
—
—
—
—
—
-1.0e+50
8.8e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.55%
cases:4.39%
controls:1.87%
—
—
—
—
—
0
6
116
1092
5
20
109
1048
Feeling anxious/nervous/tense
P01 [2002000798]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
Overweight
T83 [2002001126]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
carvedilol; oral
C07AG02 [21601700]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
7
114
1061
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
betamethasone
C05AA05 [21601610]
5.1e-01
—
—
—
—
—
6.9e-01
cases:5.17%
controls:3.18%
—
—
—
—
—
—
—
—
—
—
cases:6.14%
controls:3.18%
6
35
110
1065
—
—
—
—
—
7
34
107
1034
Caries of dentine
K02.1 [45548134]
—
—
—
—
—
1.0e+00
5.7e-01
—
—
—
—
—
—
—
—
—
—
cases:5.17%
controls:1.91%
cases:14.04%
controls:8.43%
—
—
—
—
—
6
21
110
1077
16
90
98
978
fluticasone; nasal
R01AD08 [21605050]
7.3e-01
—
—
—
—
1.1e+00
8.6e-01
cases:6.90%
controls:3.45%
—
—
—
—
—
—
—
—
cases:5.17%
controls:1.82%
cases:12.28%
controls:5.62%
8
38
108
1062
—
—
—
—
6
20
110
1078
14
60
100
1008
Glucose tolerance 2 hours panel - Serum or Plasma
72171-2 [43054914]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
acetylsalicylic acid; oral
B01AC06 [21600991]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
Erysipelas
A46 [45561706]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
levocabastine; nasal
R01AC02 [21605034]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.91%
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
0
10
116
1090
0
5
116
1095
—
—
—
—
—
Pathology report gross observation
24419-4 [3002256]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
7
114
1061
Bacteria [Presence] in Urine
87829-8 [36304419]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
12
116
1088
—
—
—
—
—
—
valsartan and diuretics
C09DA03 [21601836]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.45%
cases:0.00%
controls:0.45%
—
—
—
—
—
—
cases:0.00%
controls:0.46%
cases:0.00%
controls:0.56%
0
5
116
1095
0
5
116
1095
—
—
—
0
5
116
1093
0
6
114
1062
Infiltration anesthesia
WX110 [2001310767]
—
—
—
—
—
1.2e+00
-2.2e-01
—
—
—
—
—
—
—
—
—
—
cases:6.90%
controls:2.09%
cases:7.89%
controls:9.64%
—
—
—
—
—
8
23
108
1075
9
103
105
965
Teeth/gum symptom/complaint
D19 [2002000318]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
0
7
116
1091
—
Cervicocranial syndrome
M53.0 [45562750]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
Outcome of delivery
Z37 [45581024]
2.5e-01
-1.0e+50
—
—
—
—
—
cases:6.90%
controls:5.45%
cases:0.00%
controls:1.55%
—
—
—
—
—
—
—
—
—
—
8
60
108
1040
0
17
116
1083
—
—
—
—
—
rizatriptan; oral
N02CC04 [21604379]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
0
7
116
1093
—
—
—
—
—
0
6
114
1062
bisoprolol; oral
C07AB07 [21601689]
—
—
—
—
—
—
2.0e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:7.89%
controls:6.55%
—
—
—
—
—
—
9
70
105
998
SMOKING - SMOKE2: yes - SMOKE3: current - SMOKE5: current
SMOKING-1-1-1 [2002330115]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:2.27%
cases:0.00%
controls:0.82%
—
—
—
—
—
—
—
—
—
—
0
25
116
1075
0
9
116
1091
—
—
—
—
—
vortioxetine; oral
N06AX26 [44819158]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
Examination and observation for other specified reasons
Z04.8 [45552063]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.75%
—
—
—
—
—
—
0
8
114
1060
Albumin/Creatinine [Ratio] in Urine
32294-1 [3020682]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.73%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
116
1092
—
—
—
—
—
—
One hour or less
ZXE00 [2001311394]
6.0e-01
—
—
—
—
—
4.3e-01
cases:6.90%
controls:3.91%
—
—
—
—
—
—
—
—
—
—
cases:7.02%
controls:4.68%
8
43
108
1057
—
—
—
—
—
8
50
106
1018
acrivastine; oral
R06AX18 [21603518]
—
—
—
—
—
—
4.8e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:7.89%
controls:5.06%
—
—
—
—
—
—
9
54
105
1014
measles, combinations with mumps, rubella and varicella, live attenuated
J07BD54 [21601346]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
116
1095
—
—
—
—
—
—
Conjunctivitis
H10 [45581570]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
0
5
114
1063
Audiology
64 [38004489]
—
—
—
1.0e+50
—
—
1.3e+00
—
—
—
—
—
—
cases:4.31%
controls:0.00%
—
—
—
—
cases:6.14%
controls:1.69%
—
—
—
5
0
111
1100
—
—
7
18
107
1050
tiotropium bromide; inhalant
R03BB04 [21603296]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
6
114
1062
Vascular Surgery
77 [38004496]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
116
1093
—
—
—
—
—
—
Complicated extraction of tooth
EBA05 [2001301924]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.03%
—
—
—
—
—
—
0
11
114
1057
other preparations, combinations; ointment
C05AX03 [21601631]
—
-1.0e+50
—
—
—
—
1.1e+00
—
—
cases:0.00%
controls:0.64%
—
—
—
—
—
—
—
—
cases:4.39%
controls:1.50%
—
0
7
116
1093
—
—
—
—
5
16
109
1052
insulins and analogues for injection, intermediate-acting - combinations; parenteral
A10AC30 [21600727]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:1.18%
cases:0.00%
controls:0.82%
—
—
—
—
—
—
cases:0.00%
controls:0.73%
cases:0.00%
controls:1.87%
0
13
116
1087
0
9
116
1091
—
—
—
0
8
116
1090
0
20
114
1048
metronidazole
D06BX01 [21602096]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.82%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
116
1091
—
—
—
—
—
—
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.73%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
116
1092
—
—
—
—
—
—
Health maint/preventive medicine
A98 [2002000231]
-1.6e-02
1.3e-01
—
—
—
3.1e-01
1.6e-01
cases:6.90%
controls:7.00%
cases:7.76%
controls:6.91%
—
—
—
—
—
—
cases:9.48%
controls:7.10%
cases:21.05%
controls:18.45%
8
77
108
1023
9
76
107
1024
—
—
—
11
78
105
1020
24
197
90
871
Periodontitis NOS
K05.32 [2000502730]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
6
114
1062
Functional capacity evaluation
443351003 [40481051]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.66%
—
—
—
—
—
—
0
7
114
1061

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
92
622
1.56
3.59
1.9
1.6
—
—
—
0
0
80
548
1.53
2.96
9.8
8.5
104.64
104.57
mmol/l
0.05
80
548
60
405
1.53
2.40
11.5
10.8
7.42
7.42
ph
0.04
22
212
40
251
1.63
2.18
15.5
12.5
95.79
93.99
%
3.06
40
251
58
399
1.50
2.14
11.6
10.8
0.97
0.79
mmol/l
0.12
50
330
74
994
0.71
2.05
1.3
1.3
11.31
8.54
u/ml
0.14
35
404
178
1498
1.26
1.85
3.1
3.3
45.16
42.55
e6/l
0.05
142
1106
5
12
4.19
1.82
33.6
8.1
5.14
5.03
kpa
—
5
12
5
12
4.19
1.82
33.6
8.1
5.62
5.95
kpa
—
5
12
7
26
2.71
1.58
1.0
1.2
580.43
691.29
u/l
—
7
21
12
233
0.51
1.57
1.1
1.1
8.63
7.11
u/ml
—
6
144
147
1232
1.25
1.57
3.9
3.4
—
0.00
—
0
6
14
258
0.53
1.56
1.1
1.2
11.31
3.81
u/ml
—
8
146
0
43
0.00
1.52
0.0
1.2
—
—
—
0
0
120
989
1.26
1.48
2.4
2.8
8.59
7.45
e6/l
0.28
111
884
33
220
1.53
1.46
18.0
13.0
24.30
24.39
mmol/l
0.06
33
215
12
226
0.52
1.44
1.1
1.1
6.00
1.28
u/ml
—
6
112
56
417
1.38
1.42
17.1
11.3
—
—
—
0
0
6
23
2.62
1.37
5.3
3.4
—
—
—
0
0
30
200
1.52
1.35
1.1
1.1
4.58
7.17
eliau/ml
—
8
35
184
1607
1.21
1.32
2.3
2.2
—
—
—
0
0
151
1294
1.22
1.31
3.2
3.2
0.49
0.26
e6/l
0.53
116
914
77
610
1.30
1.30
1.3
1.4
—
—
—
0
0
59
451
1.34
1.28
9.9
6.9
1.92
1.55
mmol/l
0.32
53
384
60
460
1.34
1.28
8.5
6.9
7.37
7.38
ph
0.18
38
279
21
130
1.64
1.28
1.2
1.2
—
—
—
0
0
149
1281
1.21
1.25
2.8
2.5
—
—
—
0
0
51
385
1.35
1.21
16.6
10.3
1.21
1.30
mmol/l
0.30
51
377
9
168
0.53
1.20
1.2
1.2
—
—
—
0
0
60
465
1.32
1.20
8.5
6.7
5.92
5.82
kpa
0.39
60
457
7
31
2.27
1.10
1.1
1.2
—
—
—
0
0
8
41
1.96
1.09
1.1
1.1
1514.25
1523.80
miu/ml
—
8
41
102
1202
0.82
1.07
1.7
1.9
—
—
—
0
0
53
412
1.31
1.06
7.9
6.5
4.81
4.80
kpa
0.01
53
406
303
2803
1.16
1.04
4.0
3.3
0.00
5.24
estimate
0.80
58
556
19
122
1.57
1.03
3.5
2.8
2.14
2.55
index
—
7
70
161
1814
0.85
1.03
1.8
1.7
—
—
—
0
0
205
1844
1.17
1.02
3.9
4.0
65.42
67.30
e6/l
0.02
147
1202
5
106
0.47
1.02
2.6
2.2
127.60
132.97
g/l
—
5
88
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
27
374
0.71
0.96
1.6
1.5
66.75
62.56
ug/l
0.22
19
316
92
1078
0.83
0.92
1.3
1.3
19.25
23.53
iu/ml
0.32
25
322
79
939
0.82
0.91
3.9
3.0
133.09
99.65
ug/g
0.50
65
747
49
386
1.29
0.91
1.7
2.0
6.11
6.21
ph
0.24
27
232
298
2773
1.14
0.91
3.9
3.3
0.00
0.00
estimate
0.50
56
558
303
2823
1.14
0.91
4.0
3.4
0.00
0.01
estimate
0.80
54
527
8
43
1.87
0.87
1.3
1.4
88.75
74.00
umol/l
—
8
43
29
214
1.37
0.84
9.9
5.5
0.59
0.62
%
0.20
29
214
196
2145
0.87
0.83
1.9
1.9
1.36
1.39
mmol/l
0.24
179
1903
45
357
1.28
0.81
16.3
12.1
25.06
24.94
mmol/l
0.10
45
357
29
216
1.36
0.80
2.4
3.2
76.04
103.53
ng/l
0.46
23
194
95
823
1.18
0.76
3.7
3.3
234.91
630.98
ng/l
0.86
58
489
77
655
1.20
0.75
2.1
2.0
—
—
—
0
0
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
34
433
0.77
0.73
1.4
1.6
—
—
—
0
0
50
408
1.24
0.73
3.8
5.4
0.00
0.16
%
—
10
93
230
2134
1.12
0.70
3.7
3.1
0.00
0.03
estimate
1.73
51
476
360
3766
0.90
0.68
8.1
7.4
84.15
78.51
u/l
0.37
347
3587
501
5139
0.87
0.66
4.0
4.2
1.45
1.44
mmol/l
0.22
485
4912
5
28
1.79
0.66
7.6
3.6
—
—
—
0
0
41
502
0.80
0.66
1.6
1.9
—
—
—
0
0
14
201
0.69
0.65
1.6
1.4
—
—
—
0
0
7
44
1.60
0.65
1.9
1.5
0.56
0.50
e9/l
—
7
44
8
128
0.62
0.64
1.1
1.4
12.88
17.59
u/l
—
8
108
210
1951
1.11
0.62
5.5
5.4
37.00
37.36
g/l
0.44
202
1854
25
191
1.32
0.62
2.8
6.8
—
—
—
0
0
50
418
1.21
0.61
4.2
4.9
0.88
0.94
%
0.05
13
124
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
79
690
1.17
0.60
3.1
2.5
2.39
2.42
g/l
0.19
72
640
182
1963
0.90
0.59
1.9
1.9
—
—
—
0
0
48
401
1.21
0.59
4.2
5.0
0.18
0.15
%
0.09
11
106
26
331
0.78
0.59
1.0
1.1
—
—
—
0
0
32
396
0.80
0.58
1.2
1.3
—
23.70
—
0
23
47
393
1.21
0.58
3.8
4.9
0.18
0.65
%
1.83
11
110
86
761
1.15
0.55
3.2
3.0
3.06
2.93
e6/l
0.05
41
354
12
171
0.70
0.55
1.2
1.1
5.89
5.90
u/ml
—
7
79
84
746
1.15
0.52
3.1
2.6
14.08
14.63
umol/l
0.27
79
700
508
5187
0.89
0.52
4.5
4.6
2.92
2.83
mmol/l
1.56
492
4958
23
292
0.78
0.52
1.6
1.6
—
—
—
0
0
505
5158
0.89
0.52
4.1
4.2
4.79
4.72
mmol/l
1.01
489
4953
61
529
1.17
0.52
1.6
1.6
914.28
1193.63
nmol/l
2.04
48
420
90
807
1.13
0.49
1.8
1.6
445.66
46345251.70
pmol/l
1.29
79
725
27
333
0.80
0.49
1.5
1.7
0.38
0.29
mg/l
0.40
13
154
105
1155
0.89
0.49
2.7
2.7
333.52
329.22
umol/l
0.17
96
1069
150
1387
1.11
0.49
5.5
4.6
—
—
—
0
0
36
300
1.21
0.47
1.9
3.6
89.99
73.54
e9/l
0.53
23
205
7
48
1.46
0.47
1.7
2.1
—
—
—
0
0
17
219
0.77
0.44
1.1
1.1
—
—
—
0
0
557
5645
0.88
0.43
10.6
10.3
—
—
—
0
0
62
549
1.14
0.42
1.5
1.4
—
—
—
0
0
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
493
4829
1.10
0.41
16.1
15.0
13.34
13.28
%
0.48
486
4786
0
15
0.00
0.41
0.0
1.1
—
14.78
—
0
15
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
174
1847
0.92
0.40
2.0
2.2
—
—
—
0
0
5
34
1.47
0.40
2.2
2.8
—
—
—
0
0
395
4061
0.93
0.40
3.5
3.4
39.58
39.01
u/l
0.07
383
3935
23
281
0.81
0.40
1.6
1.5
1.31
1.28
mm
0.08
14
201
292
2805
1.08
0.39
6.2
5.3
6.37
6.41
mmol/l
0.12
265
2595
7
104
0.67
0.39
2.6
2.6
—
19.36
—
0
5
29
345
0.83
0.39
3.1
4.0
7.31
7.35
ph
0.34
22
260
9
67
1.35
0.38
1.2
1.2
—
—
—
0
0
57
507
1.14
0.37
3.9
2.5
37.67
30.68
u/l
1.38
48
420
57
637
0.88
0.36
1.5
1.6
1082.18
998.14
mu/l
0.20
45
535
40
348
1.16
0.35
1.4
1.3
263.87
250.33
miu/ml
0.08
22
175
24
287
0.83
0.35
1.6
1.5
—
—
—
0
0
10
134
0.74
0.35
1.0
1.2
—
—
—
0
0
528
5200
1.10
0.34
13.8
12.7
139.58
139.60
mmol/l
0.06
515
5092
241
2511
0.93
0.34
10.6
10.0
0.00
0.00
e9/l
0.28
189
2021
144
1529
0.92
0.34
2.9
3.0
24.48
37.68
ng/l
0.53
77
771
135
1266
1.08
0.34
2.6
2.4
2.61
2.56
mg/l
0.08
120
1102
475
4835
0.93
0.33
3.4
3.6
1.28
1.26
mmol/l
0.36
457
4591
457
4657
0.93
0.32
4.9
4.9
37.73
37.60
mmol/mol
0.11
440
4471
194
1849
1.07
0.32
1.9
1.8
97.38
96.17
pmol/l
0.14
106
988
6
47
1.28
0.32
7.2
7.9
5.90
6.77
mmol/l
—
6
41
19
230
0.82
0.32
1.5
2.4
—
—
—
0
0
235
2445
0.94
0.32
2.6
2.6
—
—
—
0
0
259
2686
0.94
0.32
7.4
6.9
28.65
29.87
%
1.10
248
2577
7
100
0.70
0.30
4.0
3.6
18.86
25.56
nmol/l
—
7
94
39
344
1.14
0.30
2.7
2.5
0.24
0.40
e6/l
0.25
34
327
7
55
1.28
0.30
10.9
11.3
9.59
11.50
%
—
7
55
251
2601
0.94
0.30
7.6
7.0
8.49
8.41
%
0.18
236
2470
239
2300
1.06
0.30
3.7
3.1
6.16
6.20
ph
0.22
133
1320
283
2922
0.94
0.30
7.5
7.3
0.19
0.18
e9/l
0.17
254
2560
11
141
0.78
0.29
1.0
2.1
4.57
3.62
mmol/l
0.45
11
134
251
2598
0.94
0.28
7.5
6.9
2.72
2.82
%
0.31
237
2457
152
1444
1.07
0.28
4.0
3.4
0.04
0.01
estimate
0.39
56
537
22
186
1.19
0.28
1.0
1.1
—
—
—
0
0
22
186
1.19
0.28
1.0
1.1
—
—
—
0
0
15
183
0.82
0.28
1.3
1.6
0.26
0.23
g/l
0.47
15
175
474
4814
0.94
0.27
3.9
3.9
5.71
5.71
mmol/l
0.01
450
4535
112
1187
0.93
0.26
3.5
3.7
199.54
53.25
mg/l
0.47
79
800
9
73
1.24
0.25
1.2
1.3
15.96
200.61
mu/l
—
9
66
202
1944
1.06
0.25
9.9
7.5
1.21
1.21
mmol/l
0.77
192
1820
6
81
0.74
0.24
1.0
1.1
—
—
—
0
0
6
81
0.74
0.24
5.8
3.3
—
—
—
0
0
338
3301
1.05
0.24
4.2
4.0
19.00
481.00
e6/l
—
6
42
6
85
0.70
0.24
1.8
1.7
25.02
26.84
ng/l
—
6
85
247
2394
1.05
0.23
2.8
2.7
—
—
estimate
—
0
0
228
2206
1.05
0.23
9.6
7.7
1.21
1.21
mmol/l
0.26
210
1948
144
1506
0.94
0.23
4.1
2.7
59.40
59.09
u/l
0.02
136
1418
55
596
0.92
0.22
1.1
1.2
—
—
—
0
0
5
42
1.19
0.21
4.2
2.4
1.14
1.19
mmol/l
—
5
42
5
42
1.19
0.21
4.2
2.4
105.80
105.93
mmol/l
—
5
42
5
42
1.19
0.21
4.2
2.4
4.16
3.98
mmol/l
—
5
42
0
11
0.00
0.21
0.0
25.4
—
0.49
—
0
11
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.6
—
126.44
—
0
11
0
11
0.00
0.21
0.0
1.0
—
64.00
—
0
11
0
10
0.00
0.21
0.0
1.9
—
2.50
—
0
10
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
15
126
1.19
0.21
1.0
1.1
2.51
1.95
eliau/ml
—
9
63
69
645
1.08
0.21
1.3
1.4
—
—
—
0
0
252
2588
0.96
0.20
7.6
7.0
0.65
0.68
%
0.50
238
2443
10
80
1.25
0.20
8.7
4.3
4.64
4.00
e9/l
—
10
80
10
123
0.81
0.20
1.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
18
155
1.17
0.20
9.8
8.8
—
—
—
0
0
41
375
1.10
0.20
1.0
1.2
—
176.25
—
0
8
22
193
1.14
0.20
1.7
1.5
129.69
214.48
u/ml
1.57
13
109
48
519
0.92
0.19
1.2
1.4
30.69
20.81
iu/l
1.22
43
431
45
414
1.09
0.19
2.9
3.3
—
—
—
0
0
26
291
0.89
0.19
2.7
4.7
109.08
22.14
ug/l
0.37
17
229
59
632
0.93
0.19
1.5
1.6
—
—
—
0
0
259
2655
0.96
0.19
6.9
6.7
56.86
55.78
%
0.87
249
2558
171
1651
1.05
0.19
3.1
2.6
0.02
0.02
estimate
0.08
51
461
154
1597
0.95
0.19
5.2
6.0
—
—
—
0
0
7
58
1.21
0.18
1.3
1.5
26.93
34.57
nmol/l
—
7
47
534
5384
0.94
0.18
12.8
12.2
23.16
20.82
mg/l
0.75
439
4271
14
119
1.18
0.18
1.3
1.2
—
—
—
0
0
7
61
1.15
0.17
1.0
1.3
20.11
10.54
u/l
—
7
55
82
863
0.94
0.17
1.4
1.4
402.35
517.86
titre
0.46
17
168
69
651
1.07
0.17
3.1
3.1
4.13
5.80
e9/l
1.01
63
595
7
63
1.11
0.17
2.3
1.9
—
—
—
0
0
5
66
0.76
0.17
1.2
1.8
—
—
—
0
0
5
67
0.74
0.17
1.4
1.3
—
—
—
0
0
17
194
0.87
0.17
1.5
2.2
6.84
4.19
iu/l
—
9
82
5
69
0.72
0.17
2.6
2.3
18.12
17.43
%
—
5
69
8
70
1.14
0.16
1.1
1.4
—
—
—
0
0
26
287
0.90
0.16
6.8
2.0
81.32
37.52
u/ml
0.53
26
272
142
1469
0.96
0.16
1.3
1.5
2.06
2.15
g/l
0.35
96
938
52
487
1.07
0.16
1.3
1.3
225.31
291.57
u/ml
0.23
47
453
27
245
1.11
0.15
2.2
3.6
21.44
21.12
s
0.16
27
223
16
182
0.88
0.15
2.6
2.1
—
—
—
0
0
34
313
1.09
0.15
1.5
1.2
—
—
—
0
0
23
254
0.90
0.14
1.3
1.3
—
—
—
0
0
51
541
0.94
0.14
1.5
1.9
—
—
—
0
0
10
84
1.19
0.14
1.7
2.7
—
—
—
0
0
132
1279
1.04
0.13
5.9
3.8
7.39
7.40
ph
0.20
88
885
129
1331
0.96
0.13
2.5
2.1
163.07
229.78
u/l
0.61
123
1278
110
1138
0.96
0.13
1.8
1.5
19.20
20.65
nmol/l
0.57
100
1008
9
110
0.82
0.13
1.0
1.1
—
—
—
0
0
31
334
0.92
0.12
2.1
1.9
—
—
—
0
0
35
326
1.08
0.12
1.1
1.1
1.53
1.52
g/l
0.01
35
326
427
4312
0.97
0.12
4.4
4.3
14.44
14.43
pmol/l
0.00
408
4048
524
5204
1.04
0.12
14.1
12.8
3.94
3.93
mmol/l
0.62
509
5082
91
878
1.04
0.11
2.8
2.8
569.84
553.60
mosm/kgh2o
0.23
81
762
43
407
1.06
0.10
1.8
2.0
0.00
0.03
estimate
—
7
113
13
146
0.89
0.10
1.6
1.4
82.92
80.33
pmol/l
0.03
13
140
52
545
0.95
0.10
1.5
1.9
—
—
—
0
0
5
45
1.11
0.10
1.2
1.0
—
—
—
0
0
117
1201
0.97
0.10
4.0
4.3
5.95
8.89
mg/mmol
0.79
79
784
35
330
1.06
0.09
1.1
1.1
0.96
0.90
g/l
0.62
35
330
130
1270
1.03
0.09
4.2
3.3
1.02
1.02
kg/l
0.85
75
827
6
55
1.09
0.09
1.2
1.0
—
—
—
0
0
192
1952
0.98
0.08
3.7
3.4
79.93
31.40
u/l
0.47
182
1872
5
64
0.78
0.08
1.2
1.2
—
—
—
0
0
52
541
0.96
0.08
1.5
1.9
—
—
—
0
0
53
551
0.96
0.08
1.1
1.3
116.86
158.46
u/ml
0.31
23
230
152
1549
0.98
0.08
3.5
3.6
8.27
8.49
mmol/l
0.17
131
1375
168
1652
1.02
0.07
1.3
1.4
1.03
2.11
u/ml
1.35
46
434
71
689
1.03
0.07
1.6
1.7
3.68
3.48
mmol/l
0.58
41
485
147
1496
0.98
0.07
1.8
1.8
—
—
—
0
0
52
539
0.96
0.07
1.5
1.9
—
—
—
0
0
9
85
1.06
0.07
1.2
1.6
—
—
—
0
0
36
344
1.05
0.06
1.6
1.4
—
—
—
0
0
14
128
1.10
0.06
10.0
2.1
0.62
0.89
nmol/l
1.23
14
111
121
1233
0.98
0.06
1.9
2.1
0.77
1.04
mg/l
1.17
101
925
9
104
0.86
0.06
1.2
1.1
—
—
—
0
0
58
598
0.97
0.06
1.1
1.2
—
—
—
0
0
120
1178
1.02
0.06
1.6
1.6
—
—
—
0
0
11
121
0.91
0.06
1.0
2.4
—
—
—
0
0
286
2885
0.98
0.06
7.2
6.9
1.90
2.02
e9/l
1.20
260
2553
315
3124
1.02
0.06
9.0
9.7
4.10
3.94
e9/l
0.61
276
2705
17
182
0.93
0.05
1.4
1.6
—
—
—
0
0
279
2814
0.98
0.05
7.2
6.9
0.56
0.54
e9/l
0.51
250
2427
562
5636
0.97
0.05
10.5
10.1
27.92
27.82
u/l
0.04
549
5527
19
202
0.94
0.05
1.5
2.0
257.95
217.48
pmol/l
1.03
19
194
330
3278
1.01
0.04
3.1
3.1
—
12627.25
—
0
8
297
2949
1.01
0.04
3.4
3.2
87.08
90.12
ug/l
0.15
285
2828
248
2499
0.99
0.04
5.4
6.3
11.45
11.13
umol/l
0.10
233
2391
24
251
0.95
0.04
1.3
2.0
4.10
4.60
iu/ml
—
5
54
496
4976
0.98
0.04
5.1
5.2
1.85
1.77
mu/l
0.96
481
4743
20
190
1.05
0.04
1.2
1.2
—
—
—
0
0
76
772
0.98
0.03
2.2
2.4
2.44
2.42
mmol/l
0.76
68
688
280
2815
0.99
0.03
7.2
6.9
0.04
0.04
e9/l
0.02
250
2428
11
102
1.08
0.03
2.5
2.2
—
—
—
0
0
157
1556
1.01
0.03
2.5
3.0
2.37
2.36
mmol/l
0.83
141
1455
11
118
0.93
0.03
8.3
3.6
59.49
58.07
%
0.16
11
118
18
172
1.05
0.02
1.9
1.6
153.25
133.89
au/ml
—
8
59
601
6017
0.97
0.02
19.3
18.4
6.70
6.67
e9/l
0.10
589
5908
12
113
1.06
0.01
1.1
1.1
59.60
90.65
iu/ml
—
5
28
15
143
1.05
0.01
1.4
1.8
—
—
—
0
0
48
472
1.02
0.01
2.2
2.3
5347.42
6073.71
u/l
0.07
21
199
98
973
1.01
0.00
1.7
1.7
—
—
—
0
0
19
184
1.03
0.00
1.5
1.4
—
87.39
—
0
23
20
194
1.03
0.00
2.0
2.1
—
—
—
0
0
178
1773
1.01
0.00
15.1
8.6
1.19
1.12
inr
1.11
143
1478
565
5655
0.99
0.00
14.5
13.8
74.05
71.00
umol/l
0.80
559
5590
11
111
0.99
0.00
1.3
1.3
2.40
4.08
u/ml
—
5
53
601
6014
0.98
0.00
19.3
18.4
4.61
4.60
e12/l
0.05
589
5911
11
114
0.96
0.00
2.3
2.3
7.41
7.41
ph
0.10
11
114
19
185
1.03
0.00
1.5
1.2
—
—
—
0
0
18
175
1.03
0.00
1.9
1.7
—
—
—
0
0
15
146
1.03
0.00
1.6
1.4
380.25
296.53
ug/g
—
8
75
76
755
1.01
0.00
6.4
4.8
0.80
0.82
mmol/l
0.86
70
729
65
649
1.00
0.00
1.3
1.2
—
—
—
0
0
37
368
1.01
0.00
1.1
1.1
—
—
—
0
0
601
6009
1.00
0.00
19.3
18.4
266.05
259.67
e9/l
1.68
589
5915
26
264
0.98
0.00
4.1
6.0
—
—
—
0
0
35
346
1.01
0.00
3.5
5.7
7.40
7.41
ph
0.76
26
285
34
335
1.02
0.00
1.5
1.5
—
—
—
0
0
109
1095
0.99
0.00
3.4
4.0
—
—
—
0
0
37
370
1.00
0.00
1.1
1.2
—
—
—
0
0
234
2337
1.00
0.00
3.0
2.8
70.82
72.77
nmol/l
0.57
223
2196
62
620
1.00
0.00
2.9
3.6
4.81
7.30
umol/l
2.04
54
533
18
184
0.98
0.00
3.3
6.1
115.38
317.03
mg/l
—
8
104
57
569
1.00
0.00
2.8
2.4
0.68
0.64
ug/l
0.13
30
263
7
72
0.97
-0.00
1.1
3.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
15.40
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.0
—
—
—
0
0
6
61
0.98
-0.00
1.0
3.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
0.96
—
0
6
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
58
0.86
-0.00
1.2
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.0
—
17.02
—
0
5
0
8
0.00
-0.00
0.0
1.0
—
0.03
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
8.70
—
0
5
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
32.80
—
0
5
8
81
0.99
-0.00
2.1
2.4
—
—
—
0
0
7
72
0.97
-0.00
2.9
2.3
5.07
4.96
kpa
—
7
72
0
6
0.00
-0.00
0.0
1.8
—
343.67
—
0
6
9
96
0.94
-0.00
1.4
1.3
—
—
—
0
0
5
54
0.93
-0.00
1.0
1.1
85.20
35.22
mg/l
—
5
43
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
72
0.97
-0.00
2.9
2.3
10.14
9.43
kpa
—
7
72
5
55
0.91
-0.00
1.2
1.2
—
—
—
0
0
5
52
0.96
-0.00
1.0
1.1
302.00
211.84
mg/l
—
5
45
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
6
66
0.91
-0.00
1.2
2.8
34.01
40.77
%
—
6
66
0
7
0.00
-0.00
0.0
1.1
—
12.14
—
0
7
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
8
81
0.99
-0.00
4.8
3.9
6.78
7.21
pmol/l
—
8
81
0
5
0.00
-0.00
0.0
1.0
—
394.40
—
0
5
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.0
—
9094.67
—
0
6
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_CLEFT_LIP_CLEFT_PALATE and mortality.

Females

Parameter HR [95% CI] p-value
Q17_CLEFT_LIP_CLEFT_PALATE 1.527 [1.11, 2.1] 0.009
Birth year 0.998 [0.99, 1.01] 0.627

During the follow-up period (1.1.1998 — 31.12.2019), 53 out of 1650 females with Q17_CLEFT_LIP_CLEFT_PALATE died.

Males

Parameter HR [95% CI] p-value
Q17_CLEFT_LIP_CLEFT_PALATE 1.453 [1.11, 1.9] 0.007
Birth year 0.99 [0.98, 1.0] 0.028

During the follow-up period (1.1.1998 — 31.12.2019), 61 out of 1668 males with Q17_CLEFT_LIP_CLEFT_PALATE died.

Mortality risk

Mortality risk for people of age

years, who have Q17_CLEFT_LIP_CLEFT_PALATE.

N-year risk Females Males
1 0.107% 0.288%
5 0.868% 1.897%
10 2.146% 4.739%
15 4.504% 8.678%
20 8.001% 14.407%

Relationships between endpoints

↥

Index endpoint: Q17_CLEFT_LIP_CLEFT_PALATE – Cleft lip, lip and palate or palate

GWS hits: 5

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data